Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IMNP > SEC Filings for IMNP > Form 8-K on 3-Oct-2013All Recent SEC Filings

Show all filings for IMMUNE PHARMACEUTICALS INC

Form 8-K for IMMUNE PHARMACEUTICALS INC


3-Oct-2013

Other Events


Item 8.01 Other Events.

On September 30, 2013, Immune Pharmaceuticals Inc., formerly known as EpiCept Corporation ("Immune"), announced that NASDAQ OMX Stockholm AB has advised, and Immune has agreed, to seek the transition of its Swedish listing to NASDAQ OMX First North Premier, which maintains access to Nordic country capital and liquidity for existing shareholders, while requiring less market specific regulation. The press release is attached hereto as Exhibit 99.1.


Top of the Form

  Add IMNP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IMNP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.